Literature DB >> 9256410

Lymphotoxins: from cytotoxicity to lymphoid organogenesis.

H von Boehmer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256410      PMCID: PMC33760          DOI: 10.1073/pnas.94.17.8926

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  27 in total

1.  Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.

Authors:  P A Koni; R Sacca; P Lawton; J L Browning; N H Ruddle; R A Flavell
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

Authors:  M B Alimzhanov; D V Kuprash; M H Kosco-Vilbois; A Luz; R L Turetskaya; A Tarakhovsky; K Rajewsky; S A Nedospasov; K Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

4.  Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation.

Authors:  M Müller; H P Eugster; M Le Hir; A Shakhov; F Di Padova; C Maurer; V F Quesniaux; B Ryffel
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

5.  Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.

Authors:  B S Conta; M B Powell; N H Ruddle
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor.

Authors:  M Pasparakis; L Alexopoulou; M Grell; K Pfizenmaier; H Bluethmann; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  The differential inhibitory effect of lymphotoxin and immune interferon on normal and malignant lymphoid cells.

Authors:  M B Powell; B S Conta; M Horowitz; N H Ruddle
Journal:  Lymphokine Res       Date:  1985

8.  Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness.

Authors:  T A Banks; B T Rouse; M K Kerley; P J Blair; V L Godfrey; N A Kuklin; D M Bouley; J Thomas; S Kanangat; M L Mucenski
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

9.  Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs.

Authors:  P D Rennert; J L Browning; R Mebius; F Mackay; P S Hochman
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  9 in total

1.  Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice.

Authors:  D Kreder; O Krut; S Adam-Klages; K Wiegmann; G Scherer; T Plitz; J M Jensen; E Proksch; J Steinmann; K Pfeffer; M Krönke
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Role of lymphotoxin alpha in T-cell responses during an acute viral infection.

Authors:  M Suresh; Gibson Lanier; Mary Katherine Large; Jason K Whitmire; John D Altman; Nancy H Ruddle; Rafi Ahmed
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection.

Authors:  J Sun; F Bodola; X Fan; H Irshad; L Soong; S M Lemon; T S Chan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma.

Authors:  Feng-Hua Wang; Yun Wang; Zhen-Dong Chen; Jian-Hua Chen; Feng-Zhan Qin; Wen-Qi Jiang; Yu-Hong Li
Journal:  Med Oncol       Date:  2016-10-14       Impact factor: 3.064

5.  Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs.

Authors:  Elizabeth Alcamo; Nir Hacohen; Leah C Schulte; Paul D Rennert; Richard O Hynes; David Baltimore
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

6.  Crucial role of tumor necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp.

Authors:  M Tkachuk; S Bolliger; B Ryffel; G Pluschke; T A Banks; S Herren; R H Gisler; M H Kosco-Vilbois
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

7.  Salivary biomarkers in association with periodontal parameters and the periodontitis risk haplotype.

Authors:  Joonas Liukkonen; Ulvi K Gürsoy; Eija Könönen; Mervi Gürsoy; Jari Metso; Aino Salminen; Elisa Kopra; Matti Jauhiainen; Päivi Mäntylä; Kåre Buhlin; Susanna Paju; Timo Sorsa; Markku S Nieminen; Marja-Liisa Lokki; Juha Sinisalo; Pirkko J Pussinen
Journal:  Innate Immun       Date:  2018-09-03       Impact factor: 2.680

8.  Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function.

Authors:  L Alexopoulou; M Pasparakis; G Kollias
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

9.  A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.

Authors:  P A Koni; R A Flavell
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.